Arabic translation and cross‐cultural adaptation of the Bristol Activities of Daily Living Scale (BADLS)

Alkeridy, Walid; Muayqil, Taim; Khalifah, Reem Al; Mohammedin, Ahmed; Khallaf, Roaa; Bucks, Romola S.

doi:10.1002/alz.050856

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The BADLS was previously translated, cross-culturally adapted and validated for Arabic speaking people. 12 In this study we used the translated and validated Arabic version of the BADLS. 13 After reading the instruction to the caregiver of the patient living with dementia, they are instructed to choose the current level of functional ability for each item.…”

Section: Methodsmentioning

confidence: 99%

Predictors of Mortality in Home Health Care Service: Data from Saudi Arabia

Alkeridy¹,

Aljasser²,

Alayed³

et al. 2022

JMDH

View full text Add to dashboard Cite

Objective This study aimed to 1) report the prevalence of chronic conditions among Saudi people receiving long-term home health care (HHC) services, 2) identify the predictors of mortality among individuals receiving long-term HHC services, and 3) study the association between frailty and poor health outcomes among HHC users. Design Retrospective cross-sectional descriptive study. Setting and Participants A total of 555 participants were recruited from HHC services at King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia. We collected the data from electronic health records (EHR), patient charts, and caregiver interviews for 555 participants included in HHC program from the year 2019 to 2022. Methods Only individuals fulfilling the HHC program’s eligibility criteria were included to the study. A total of 555 participants were included in the analysis. We assessed the functional performance by the Katz activity of daily living and Bristol Activity of Daily Living Scale (BADLS). A trained health care provider assessed frailty using the Clinical Frailty Scale (CFS). We calculated the means and frequency to describe the prevalence of chronic conditions and variables of interest. A Chi-square test or independent-samples t -test was run to determine if there were differences between the alive and deceased individuals. A binary logistic regression model was performed to predict mortality of HHC service recipients. Results The mean age for deceased individuals in HHC was 78.3 years. Over twenty percent of individuals receiving HHC services were readmitted to the hospital. We found that the strongest predictors for mortality were pressure ulcers with an odds ratio of 3.75 and p-value of <0.0001, and the Clinical Frailty Scale, which had an odds ratio of 1.69 and p-value of 0.002, using multivariate regression analysis. Conclusions and Implications In conclusion, our study found that pressure ulcers and frailty are the strongest predictors of mortality for individuals receiving home health care services.

show abstract

Section: Methodsmentioning

confidence: 99%

Predictors of Mortality in Home Health Care Service: Data from Saudi Arabia

Alkeridy¹,

Aljasser²,

Alayed³

et al. 2022

JMDH

View full text Add to dashboard Cite

show abstract

“…25 Initial key work has been published documenting use in Saudi individuals of the MMSE, the Montreal Cognitive Assessment (MoCA), the Bristol activity of daily living scale, and the NPI in Saudi individuals. [25][26][27][28] The Arabic version of the battery of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) was validated in older Omanis. 29 Some additional tools, including the CDR and the ADAS-Cog, were validated in other Arab countries.…”

Section: Clinical Practice Recommendationsmentioning

confidence: 99%

The future of alzheimer disease immunotherapies in Saudi Arabia: Consensus statement of the Saudi Chapter of Cognitive and Behavioral Neurology

Tayeb

Khallaf

Muayqil

et al. 2023

NSJ

Self Cite

View full text Add to dashboard Cite

Alzheimer Disease (AD) constitutes a major global healthcare problem. Standard AD pharmacotherapies offer only modest transient cognitive and behavioral benefits. Aducanumab, an amyloid monoclonal antibody, was the first disease modifying agent to be approved for AD treatment. However, concerns about its efficacy and side effects led regulatory institutions around the world to restrict its use. Lecanemab was the second amyloid antibody to receive accelerated approval for use in early AD. This review and consensus statement was prepared by the Saudi Chapter of Cognitive and Behavioral Neurology to review the current developments in AD immunotherapies from a Saudi perspective. We outline recommendations with regards to offering aducanumab and other future immunotherapies to Saudi AD patients. We describe resources,

show abstract

Cognitive decline assessment in speakers of understudied languages

Hatahet,

Roser,

Seghier

2023

A&D Transl Res & Clin Interv

View full text Add to dashboard Cite

Projected trends in population aging have forecasted a massive increase in the number of people with dementia, in particular in sub‐Saharan Africa and the Middle East and North Africa (MENA) region. Cognitive decline is a significant marker for dementia, typically assessed with standardized neuropsychological tools that have been validated in some well‐researched languages such as English. However, with the existing language diversity, current tools cannot cater to speakers of understudied languages, putting these populations at a disadvantage when it comes to access to early and accurate diagnosis of dementia. Here, we shed light on the detrimental impact of this language gap in the context of the MENA region, highlighting inadequate tools and an unacceptable lack of expertise for a MENA population of a half billion people. Our perspective calls for more research to unravel the exact impact of the language gap on the quality of cognitive decline assessment in speakers of understudied languages.Highlights Cognitive decline is a marker for dementia, assessed with neuropsychological tests. There is a lack of culturally valid tests for speakers of understudied languages. For example, suboptimal cognitive tests are used in the Middle East and North Africa region. Linguistic diversity should be considered in the development of cognitive tests.

show abstract

Arabic translation and cross‐cultural adaptation of the Bristol Activities of Daily Living Scale (BADLS)

Cited by 4 publications

References 0 publications

Predictors of Mortality in Home Health Care Service: Data from Saudi Arabia

Predictors of Mortality in Home Health Care Service: Data from Saudi Arabia

The future of alzheimer disease immunotherapies in Saudi Arabia: Consensus statement of the Saudi Chapter of Cognitive and Behavioral Neurology

Cognitive decline assessment in speakers of understudied languages

Contact Info

Product

Resources

About